Uber-Backed Lime Plans Debt as IPO Push Faces Market Test
Lime, the e-scooter and e-bike maker backed by Uber, aims for a 2026 IPO, even as mounting debt and a tighter funding...
Withdrawal Strategy After Rebalancing Sp 500
Plan a withdrawal strategy post-rebalancing for SP 500 holdings to sustain income while managing risk.
24,074 articles
Tesla Sinks as Musk Heads to China with Robotaxi Glitches
Tesla stock slides roughly 5% intraday as Elon Musk travels to China amid reports of robotaxi glitches and battery pr...
Rate Brings Arizona-Based Kelsey Marquardt on Board
Rate has added Scottsdale, Arizona-based loan originator Kelsey Marquardt to its Chicago-based mortgage platform, sig...
Should Percent Closed-End Fund Be Part of Your Plan
A 68-year-old couple has relied on an 8% yield from a long-held closed-end fund for over a decade, sparking debate am...
Boos, AI-Washing, and Low-Value Human Capital in 2026
In 2026, misfired AI layoff messaging draws public boos and investor scrutiny. This report traces how leaders’ word c...
Godfather Ties to $245 Million Bitcoin Heist Case Grows
A California crypto executive dubbed 'The Godfather' pleads guilty to conspiring in a scheme tied to a $245 million b...
Jensen Huang Sounds Eerily Like Buffett as AI Dip Buy Signal
NVIDIA CEO Jensen Huang positioned the latest AI stock pullback as a buying opportunity, a stance that reminds invest...
Spacex IPO: Great Fleecing Exposed in Retail Investing
SpaceX’s public debut could bring huge hype and big risks for everyday investors. This guide breaks down the mechanic...
Beazer Refinancing Raises Dream Finders Deal Cost Impact
Beazer Homes priced a new debt issue, extending maturities and boosting liquidity, but the refinancing introduces a s...
Super Micro Computer Trading: Is the Dip a Buy Today?
Super Micro Computer's stock has swung wildly in the AI era. This guide explains what the current valuation means, ho...
Ford Realized Wasn’t Capable: 350 Veteran Engineers Lead AI
Ford shifts AI strategy by adding 350 veteran engineers to steer its tools, citing early limits of automation and a r...
Revolution Medicines Nearly 140% Rally — Is It Still a Buy?
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status